title: Late HIV Diagnosis: Proposed Common Definitions and Associations With Short-Term Mortality.
abstract: The aim of this study was to present a definition of late presentation according to different time periods between initial diagnosis of human immunodeficiency virus (HIV) infection and acquired immune deficiency syndrome (AIDS) diagnosis which would reliably identify individuals with high risk of mortality within 1 year of diagnosis, and could be used as a suggested common definition.Data of individuals diagnosed from 1994 to February 2012 in Wuhan, China were extracted retrospectively from the national HIV surveillance system. Four time periods (1, 3, 6, and 12 months) combined with the European consensus definition of advanced HIV disease (AHD) were compared. The predictive ability of each definition for identifying an individual who died within 1 year after HIV diagnosis was assessed.A total of 980 patients were included, of whom 289 (29.49%), 324 (33.06%), 353 (36.02%), and 387 (39.49%) were defined as AHD according to the definition of a CD4 count <200 cells/μL or AIDS-defining event (ADE) within 1, 3, 6, and 12 months of HIV diagnosis, respectively. One hundred twenty-seven (12.96%) patients died within 1 year of diagnosis. The highest Youden's index and largest area under the curve were presented in time period within 3 months. Time period within 1 month presented the highest consistency rate, positive likelihood ratio, and kappa value. Longer time periods increased the sensitivity but decreased the specificity.Given the European consensus definitions and the current results, we suggested that AHD could be defined as "a first-reported CD4 count <200 cells/μL or an ADE within 1 month after HIV diagnosis." "Late presentation" could be defined as "a first-reported CD4 count <350 cells/μL or an ADE within 1 month after HIV diagnosis."
authors.affiliation: From the Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China (HJ, JL, ZZ, LL, SN); and Wuhan Center for Disease Control and Prevention, Wuhan, China (NX, ZY, XW).
authors.forename: Hongbo
authors.initials: H
authors.lastname: Jiang
authors.forename: Nianhua
authors.initials: N
authors.lastname: Xie
authors.forename: Jianhua
authors.initials: J
authors.lastname: Liu
authors.forename: Zhixia
authors.initials: Z
authors.lastname: Zhang
authors.forename: Li
authors.initials: L
authors.lastname: Liu
authors.forename: Zhongzhao
authors.initials: Z
authors.lastname: Yao
authors.forename: Xia
authors.initials: X
authors.lastname: Wang
authors.forename: Shaofa
authors.initials: S
authors.lastname: Nie
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000175:diagnosis / Q000276:immunology / Q000401:mortality / Q000635:transmission; D000328:Adult; D018791:CD4 Lymphocyte Count / Q000706:statistics & numerical data*; D002681:China / Q000453:epidemiology; D057210:Delayed Diagnosis / Q000401:mortality / Q000517:prevention & control; D005260:Female; D015658:HIV Infections / Q000175:diagnosis / Q000276:immunology / Q000401:mortality / Q000635:transmission; D006801:Humans; D008297:Male; D008875:Middle Aged; D062072:Patient Acuity; D018570:Risk Assessment; D016019:Survival Analysis; D061665:Time-to-Treatment